Fingerprint
Dive into the research topics of 'Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Siddharth Singh, Herbert C. Heien, Lindsey Sangaralingham, Nilay D. Shah, William J. Sandborn
Research output: Contribution to journal › Article › peer-review